Company intelligence / Profile preview

Curaleaf

New York City, New York, United Statescuraleaf.com ↗

Ownership: Public · CURA
Employees: ~6000
Development stage: Other

Overview

Curaleaf operates one of the largest networks of dispensaries for both medical and adult-use cannabis. It offers a wide range of products including oils, tinctures, edibles, flower pods, concentrates, mints, capsules. The company has expanded rapidly through acquisitions in both the US and Europe. Clinical results per se are not published as with traditional pharma companies; efficacy data comes from real-world use and registry studies.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculePlant-derived therapyEdible formulation therapyOil-based formulation therapy
Industry: Non-Academic Healthcare

Partnerships

Boiron (French medical cannabis trial partner)Imperial College London research collaboration

Financials

Market cap: $48.2M
Total revenue: $9.3M
Enterprise value: $67.3M

Beyond the preview

Go deeper on Curaleaf.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curaleaf.

Explore the full profile